76 related articles for article (PubMed ID: 17442496)
1. Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy.
Costelli P; Almendro V; Figueras MT; Reffo P; Penna F; Aragno M; Mastrocola R; Boccuzzi G; Busquets S; Bonelli G; Lopez Soriano FJ; Argilés JM; Baccino FM
Biochim Biophys Acta; 2007 Jul; 1770(7):1028-36. PubMed ID: 17442496
[TBL] [Abstract][Full Text] [Related]
2. Muscle myostatin signalling is enhanced in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bonetto A; Penna F; Reffo P; Bossola M; Bonelli G; Doglietto GB; Baccino FM; Rossi Fanelli F
Eur J Clin Invest; 2008 Jul; 38(7):531-8. PubMed ID: 18578694
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 is downregulated in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bossola M; Penna F; Reffo P; Bonetto A; Busquets S; Bonelli G; Lopez-Soriano FJ; Doglietto GB; Argilés JM; Baccino FM; Rossi Fanelli F
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R674-83. PubMed ID: 16614058
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
[TBL] [Abstract][Full Text] [Related]
5. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.
Hudson MB; Woodworth-Hobbs ME; Zheng B; Rahnert JA; Blount MA; Gooch JL; Searles CD; Price SR
Am J Physiol Cell Physiol; 2014 Mar; 306(6):C551-8. PubMed ID: 24336651
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation.
Costelli P; Muscaritoli M; Bossola M; Moore-Carrasco R; Crepaldi S; Grieco G; Autelli R; Bonelli G; Pacelli F; Lopez-Soriano FJ; Argilés JM; Doglietto GB; Baccino FM; Rossi Fanelli F
Int J Oncol; 2005 Jun; 26(6):1663-8. PubMed ID: 15870883
[TBL] [Abstract][Full Text] [Related]
8. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
Penna F; Bonetto A; Muscaritoli M; Costamagna D; Minero VG; Bonelli G; Rossi Fanelli F; Baccino FM; Costelli P
Int J Cancer; 2010 Oct; 127(7):1706-17. PubMed ID: 20039316
[TBL] [Abstract][Full Text] [Related]
9. Anabolic steroids activate calcineurin-NFAT signaling and thereby increase myotube size and reduce denervation atrophy.
Qin W; Pan J; Wu Y; Bauman WA; Cardozo C
Mol Cell Endocrinol; 2015 Jan; 399():336-45. PubMed ID: 25450864
[TBL] [Abstract][Full Text] [Related]
10. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway.
Semsarian C; Wu MJ; Ju YK; Marciniec T; Yeoh T; Allen DG; Harvey RP; Graham RM
Nature; 1999 Aug; 400(6744):576-81. PubMed ID: 10448861
[TBL] [Abstract][Full Text] [Related]
12. The calcineurin activity and MCIP1.4 mRNA levels are increased by innervation in regenerating soleus muscle.
Fenyvesi R; Rácz G; Wuytack F; Zádor E
Biochem Biophys Res Commun; 2004 Jul; 320(2):599-605. PubMed ID: 15219871
[TBL] [Abstract][Full Text] [Related]
13. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
14. STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-κB canonical cascade activation.
Kelleher AR; Fairchild TJ; Keslacy S
Acta Diabetol; 2010 Dec; 47(4):315-23. PubMed ID: 20640583
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin signaling and neural control of skeletal muscle fiber type and size.
Schiaffino S; Serrano A
Trends Pharmacol Sci; 2002 Dec; 23(12):569-75. PubMed ID: 12457775
[TBL] [Abstract][Full Text] [Related]
16. Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress.
Mastrocola R; Reffo P; Penna F; Tomasinelli CE; Boccuzzi G; Baccino FM; Aragno M; Costelli P
Free Radic Biol Med; 2008 Feb; 44(4):584-93. PubMed ID: 18053817
[TBL] [Abstract][Full Text] [Related]
17. Effect of moderate acute exercise on expression of mRNA involved in the calcineurin signaling pathway in human skeletal muscle.
Hitomi Y; Kizaki T; Katsumura T; Mizuno M; Itoh CE; Esaki K; Fujioka Y; Takemasa T; Haga S; Ohno H
IUBMB Life; 2003 Jul; 55(7):409-13. PubMed ID: 14584592
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2.
Sakuma K; Nishikawa J; Nakao R; Watanabe K; Totsuka T; Nakano H; Sano M; Yasuhara M
Acta Neuropathol; 2003 Mar; 105(3):271-80. PubMed ID: 12557015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
